ATE186055T1 - Rekombinante derivate des menschlichen faktors viii - Google Patents

Rekombinante derivate des menschlichen faktors viii

Info

Publication number
ATE186055T1
ATE186055T1 AT92905708T AT92905708T ATE186055T1 AT E186055 T1 ATE186055 T1 AT E186055T1 AT 92905708 T AT92905708 T AT 92905708T AT 92905708 T AT92905708 T AT 92905708T AT E186055 T1 ATE186055 T1 AT E186055T1
Authority
AT
Austria
Prior art keywords
factor viii
human factor
recombinant derivatives
recombinant
derivatives
Prior art date
Application number
AT92905708T
Other languages
English (en)
Inventor
Annelie B Almstedt
Eva Maria Hellstroem
Peter Lind
Catherine Ljung
Helena Inga Sandberg
Jack Spira
Mona Sydow-Baeckman
Helena Wiman
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE186055T1 publication Critical patent/ATE186055T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Mold Materials And Core Materials (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92905708T 1991-03-15 1992-03-11 Rekombinante derivate des menschlichen faktors viii ATE186055T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100799A SE468050C (sv) 1991-03-15 1991-03-15 Rekombinant derivat av human faktor VIII

Publications (1)

Publication Number Publication Date
ATE186055T1 true ATE186055T1 (de) 1999-11-15

Family

ID=20382191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92905708T ATE186055T1 (de) 1991-03-15 1992-03-11 Rekombinante derivate des menschlichen faktors viii

Country Status (17)

Country Link
EP (1) EP0533862B1 (de)
JP (1) JP2655752B2 (de)
AR (1) AR247590A1 (de)
AT (1) ATE186055T1 (de)
AU (1) AU650730B2 (de)
CA (1) CA2081659C (de)
DE (1) DE69230206T2 (de)
DK (1) DK0533862T3 (de)
ES (1) ES2137182T3 (de)
FI (1) FI107539B (de)
GR (1) GR3032468T3 (de)
IE (1) IE920814A1 (de)
NO (1) NO308174B1 (de)
PT (1) PT100245B (de)
SE (1) SE468050C (de)
WO (1) WO1992016557A1 (de)
ZA (1) ZA921882B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595886A (en) 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US5663060A (en) * 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5364771A (en) * 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
CA2141427C (en) 1992-07-31 2008-07-22 Mohammed Anjam Khan Expression of recombinant fusion proteins in attenuated bacteria
SE9300509D0 (sv) * 1993-02-16 1993-02-16 Kabi Pharmacia Ab Peg treatment
SE504074C2 (sv) * 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
GB9401787D0 (en) * 1994-01-31 1994-03-23 Medeva Holdings Bv Vaccine compositions
SE9303601D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Improved cell cultivation method and medium
SE9403915D0 (sv) * 1994-11-14 1994-11-14 Annelie Almstedt Process A
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US7112438B2 (en) 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
EP1048726B1 (de) * 1999-04-27 2006-07-26 Négrier, Claude Modifizierte Faktor VIII cDNA
EP1038959A1 (de) * 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Faktor VIII ohne B-Domän, der ein oder mehrere Insertionsstücke von verkürztem Intron I des Faktors IX enthält
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
EP1233064A1 (de) 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modifizierte Faktor VIII cDNA und deren Verwendung bei der Produktion von Faktor VIII
EP1283263A1 (de) * 2001-08-08 2003-02-12 Aventis Behring GmbH Modifizierte cDNA für die erhöhte Expression von Faktor VIII und seinen Derivaten
EP1284290A1 (de) * 2001-08-08 2003-02-19 Aventis Behring GmbH Erhöhung der Expression von Faktor VIII durch Insertion von spleissbaren Nukleotidsequenzen in Faktor VIII cDNA
EP1668143B1 (de) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Claden und sequenzen von adeno-assoziiertem virus (aav), diese enthaltende vektoren sowie verwendungen dafür
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
KR20080007226A (ko) * 2005-04-14 2008-01-17 체에스엘 베링 게엠베하 증가된 안정성을 가진 변형된 응고 인자 ⅷ 및 이의 유도체
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
WO2011126808A2 (en) 2010-03-29 2011-10-13 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
CN103502458B (zh) 2011-02-17 2016-11-16 宾夕法尼亚大学托管会 用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
CN105017410B (zh) * 2014-04-18 2018-06-08 北京诺思兰德生物技术股份有限公司 一种b区部分缺失型重组人凝血因子ⅷ
CN115094062A (zh) 2015-04-16 2022-09-23 埃默里大学 用于肝脏中蛋白质表达的重组启动子和载体及其用途
JP7382138B2 (ja) * 2016-10-03 2023-11-16 第一三共株式会社 Ｈｓｐａ５遺伝子のプロモーター
CN116209430A (zh) 2020-08-07 2023-06-02 阿米库斯治疗学公司 囊泡靶向蛋白及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
JPS62181786A (ja) * 1985-08-12 1987-08-10 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド 融合蛋白質の製造法
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
IL83192A (en) * 1986-07-18 1992-11-15 Gist Brocades Nv Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
DE3720246A1 (de) * 1987-06-19 1988-12-29 Behringwerke Ag Faktor viii:c-aehnliches molekuel mit koagulationsaktivitaet
DE69032043T2 (de) * 1989-11-17 1998-06-04 Chiron Corp Proteinkomplexe mit faktor viii:c-aktivität und deren herstellung
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex

Also Published As

Publication number Publication date
CA2081659A1 (en) 1992-09-16
FI925131L (fi) 1992-11-11
DE69230206T2 (de) 2000-05-18
DE69230206D1 (de) 1999-12-02
DK0533862T3 (da) 2000-01-17
AU650730B2 (en) 1994-06-30
SE9100799D0 (sv) 1991-03-15
ES2137182T3 (es) 1999-12-16
NO924395L (no) 1993-01-13
WO1992016557A1 (en) 1992-10-01
SE468050C (sv) 1998-04-27
JPH05507420A (ja) 1993-10-28
IE920814A1 (en) 1992-09-23
GR3032468T3 (en) 2000-05-31
NO924395D0 (no) 1992-11-13
PT100245B (pt) 1999-08-31
AR247590A1 (es) 1995-01-31
PT100245A (pt) 1993-07-30
ZA921882B (en) 1992-11-25
NO308174B1 (no) 2000-08-07
SE9100799L (sv) 1992-09-16
SE468050B (sv) 1992-10-26
CA2081659C (en) 2002-06-25
EP0533862A1 (de) 1993-03-31
AU1351392A (en) 1992-10-21
FI107539B (fi) 2001-08-31
JP2655752B2 (ja) 1997-09-24
FI925131A0 (fi) 1992-11-11
EP0533862B1 (de) 1999-10-27

Similar Documents

Publication Publication Date Title
DE69230206D1 (de) Rekombinante derivate des menschlichen faktors viii
FI942017A0 (fi) Ihmisen interferonin stabilointi
DE69216707D1 (de) Perfluoralkylhalogenide und Derivate
NO940219D0 (no) Rekombinante antistoffer for human terapi
FI934964L (fi) Teraupetiskt aemne
DE59208415D1 (de) 3-Hydroxy-4-aryl-5-oxo-pyrazolin Derivate
FI923379L (fi) Terapeutiska amider
NO304405B1 (no) Hudpleiesammensetninger
FI933757L (fi) Expression av rekombinantproteiner i attenuerade bakterier
DE69325658D1 (de) Substituierte thiazolidindion derivate
FI941398L (fi) Modifioituja peptidijohdannaisia
FI923119A7 (fi) Krutdriven montageanordning med magasin foer faestelement
DE69220382D1 (de) Verwendung von Peptidderivaten
FI910413A7 (fi) Tooppiset valmisteet ihmisen kynsien hoitamiseksi
FI943019A7 (fi) Terapeuttisia aineita
FI934189A7 (fi) Transdermalt terapeutiskt plaoster
FI950062L (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
DK0589086T3 (da) Tandlæge-patientstol
FI924744L (fi) Terapeutiska aemnen
DE69223686D1 (de) LFA-3-Protein und Derivate
NO922521D0 (no) Piperidinyletanolderivater med terapeutisk virkning
FI923759L (fi) Terapeutiska bensazapinfoereningar
FI941749A0 (fi) Rekombinantti-Borrelia -proteiinien valmistus
DE69710305D1 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl
ITMI920261U1 (it) Vaporizzatore per scopi medicali e cosmetici

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification